ArticleMicrobiology resource announcements2019
Draft Genome Sequence of Bacillus velezensis OSY-GA1, Which Encodes Multiple Antimicrobial Metabolites and Expresses Antimicrobial Activity against Foodborne Pathogens.
Article in Microbiology resource announcements, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Targeted Isolation of Antibiofilm Compounds from Halophytic EndophyteMicroorganisms · 2024Article
- A Review on the Biotechnological Applications of the Operational GroupMicroorganisms · 2021Review
- Bacillus velezensis UTB96 Is an Antifungal Soil Isolate with a Reduced Genome Size Compared to That of Bacillus velezensis FZB42.Microbiology resource announcements · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacillus velezensis OSY-GA1 is a Gram-positive soil bacterium that exhibits antagonistic activities against Gram-positive and Gram-negative foodborne pathogens. Here, we present the strain's draft genome, which is 4,009,999 bp long with an average G+C content of 46.2%. Genome mining analysis revealed numerous biosynthetic gene clusters encoding antimicrobials of diverse natures.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.